Kallikreins have mostly been investigated as serum markers in prostate cancer, but also in some other cancer types e.g., lung cancer where HK8 has been found to be related to favorable outcome and shown to suppress tumor invasiveness in lung cancer, while little is known about their expression in HNSCC and TSCC/BOTSCC [25]. This evidence concerns the gene KLK8 and Familial prostate cancer.